The Gulf Implantable Cardioverter-defibrillator Registry: Rationale, Methodology, and Implementation
Alawi A Alsheikh-Ali, Ahmad S Hersi, Adel K S Hamad, Ahmed R Al Fagih, Faisal M Al-Samadi, Abdulmohsen M Almusaad, Fayez A Bokhari, Fawzia Al-Kandari, Bandar S Al-Ghamdi, Najib Al Rawahi, Nidal Asaad, Salem Alkaabi, Amin Daoulah, Hosam A Zaky, Omer Elhag, Yahya S Al Hebaishi, Raed Sweidan, Haitham Alanazi, David Chase, Hani Sabbour, Mohammad Al Meheiri, Ismail Al Abri, Mohammad Amin, Khaled Dagriri, Adil O Ahmed, Azam Shafquat, Shahul Hameed Khan, Alawi A Alsheikh-Ali, Ahmad S Hersi, Adel K S Hamad, Ahmed R Al Fagih, Faisal M Al-Samadi, Abdulmohsen M Almusaad, Fayez A Bokhari, Fawzia Al-Kandari, Bandar S Al-Ghamdi, Najib Al Rawahi, Nidal Asaad, Salem Alkaabi, Amin Daoulah, Hosam A Zaky, Omer Elhag, Yahya S Al Hebaishi, Raed Sweidan, Haitham Alanazi, David Chase, Hani Sabbour, Mohammad Al Meheiri, Ismail Al Abri, Mohammad Amin, Khaled Dagriri, Adil O Ahmed, Azam Shafquat, Shahul Hameed Khan
Abstract
Background: The implantable cardioverter-defibrillator (ICD) is effective in the prevention of sudden cardiac death in high-risk patients. Little is known about ICD use in the Arabian Gulf. We designed a study to describe the characteristics and outcomes of patients receiving ICDs in the Arab Gulf region.
Methods: Gulf ICD is a prospective, multi-center, multinational, and observational study. All adult patients 18 years or older, receiving a de novo ICD implant and willing to sign a consent form will be eligible. Data on baseline characteristics, ICD indication, procedure and programing, in-hospital, and 1-year outcomes will be collected. Target enrollment is 1500 patients, which will provide adequate precision across a wide range of expected event rates.
Results: Fifteen centers in six countries are enrolling patients (Saudi Arabia, United Arab Emirates, Kuwait, Oman, Bahrain, and Qatar). Two-thirds of the centers have dedicated electrophysiology laboratories, and in almost all centers ICDs are implanted exclusively by electrophysiologists. Nearly three-quarters of the centers reported annual ICD implant volumes of ≤150 devices, and pulse generator replacements constitute <30% of implants in the majority of centers. Enrollment started in December 2013, and accrual rate increased as more centers entered the study reaching an average of 98 patients per month.
Conclusions: Gulf ICD is the first prospective, observational, multi-center, and multinational study of the characteristics and, the outcomes of patients receiving ICDs in the Arab Gulf region. The study will provide valuable insights into the utilization of and outcomes related to ICD therapy in the Gulf region.
Keywords: Arabian Gulf; implantable defibrillator; registry.
Figures
References
- Epstein AE, DiMarco JP, Ellenbogen, KA, Estes NA, 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008;51:e1–62.
- Epstein AE, DiMarco JP, Ellenbogen, KA, Estes NA, 3rd, Freedman RA, Gettes LS, et al. 2012 ACC/AHA/HRS Focused Update Incorporated into the ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61:e6–75.
- Daoulah A, Alsheikh-Ali AA, Ocheltree AH, Ocheltree S, Al-Kaabi S, Malik M, et al. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: The Gulf Brugada syndrome registry. J Electrocardiol. 2012;45:327–32.
- Hersi AS. Implantable Cardioverter Defibrillator Therapy: A Single Center Experience in Saudi Arabia [Abstract] The Open Cardiovascular Medicine Journal. 2010;4:92.
- Alsheikh-Ali AA, Alkaabi S, Elhag O, Mahmud R, Rasheed A, Al-Kasser M, et al. The implantable cardioverter-defibrillator in the united arab emirates: Preliminary findings of a national survey [Abstract] Circulation. 2012;125:515.
- Al-Rawahi N, Al-Kalbani A. Indications for cardiac devices implantation in oman [Abstract] Circulation. 2012;125:518.
- Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology) J Am Coll Cardiol. 2006;48:2360–96.
- World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–4.
- Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–92.
- Parkash R, Sapp JL, Basta M, Doucette S, Thompson K, Gardner M, et al. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Circulation Arrhythm Electrophysiol. 2012;5:706–13.
Source: PubMed